SpheroSense Technologies

SpheroSense Technologies is an early-stage medical technology company developing advanced biosensing platforms for continuous health monitoring. The company's core technology utilizes 3D photonic crystal structures and spherical micro-sensors to detect biochemical changes, with a primary focus on continuous glucose monitoring (CGM) for diabetes management. By leveraging high-precision optical sensing and responsive hydrogels, SpheroSense aims to provide more durable and accurate wearable devices that reduce the need for frequent calibration and invasive sampling. The company is a spin-off from the University of Illinois Urbana-Champaign, building upon breakthroughs in materials science to improve patient outcomes in metabolic health.